NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Operating Profit

Annual Operating Profit:

$583.00M+$188.20M(+47.67%)
December 31, 2024

Summary

  • As of today, NBIX annual operating income is $583.00 million, with the most recent change of +$188.20 million (+47.67%) on December 31, 2024.
  • During the last 3 years, NBIX annual operating profit has risen by +$375.20 million (+180.56%).
  • NBIX annual operating profit is now at all-time high.

Performance

NBIX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Quarterly Operating Profit:

$145.60M+$121.90M(+514.35%)
June 30, 2025

Summary

  • As of today, NBIX quarterly operating income is $145.60 million, with the most recent change of +$121.90 million (+514.35%) on June 30, 2025.
  • Over the past year, NBIX quarterly operating profit has dropped by -$2.30 million (-1.56%).
  • NBIX quarterly operating profit is now -21.21% below its all-time high of $184.80 million, reached on September 30, 2024.

Performance

NBIX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

TTM Operating Profit:

$499.10M-$2.30M(-0.46%)
June 30, 2025

Summary

  • As of today, NBIX TTM operating income is $499.10 million, with the most recent change of -$2.30 million (-0.46%) on June 30, 2025.
  • Over the past year, NBIX TTM operating profit has dropped by -$45.60 million (-8.37%).
  • NBIX TTM operating profit is now -15.16% below its all-time high of $588.30 million, reached on September 30, 2024.

Performance

NBIX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

NBIX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+47.7%-1.6%-8.4%
3Y3 Years+180.6%+166.2%+200.1%
5Y5 Years+157.3%+18.8%+46.5%

NBIX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+180.6%-21.2%+514.4%-15.2%+138.1%
5Y5-Yearat high+180.6%-21.2%+4596.8%-15.2%+200.1%
All-TimeAll-Timeat high+374.7%-21.2%+213.2%-15.2%+324.9%

NBIX Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$145.60M(+514.3%)
$499.10M(-0.5%)
Mar 2025
-
$23.70M(-83.7%)
$501.40M(-14.0%)
Dec 2024
$583.00M(+47.7%)
$145.00M(-21.5%)
$583.00M(-0.9%)
Sep 2024
-
$184.80M(+24.9%)
$588.30M(+8.0%)
Jun 2024
-
$147.90M(+40.5%)
$544.70M(+15.8%)
Mar 2024
-
$105.30M(-29.9%)
$470.40M(+19.1%)
Dec 2023
$394.80M(+58.6%)
$150.30M(+6.4%)
$394.80M(+13.5%)
Sep 2023
-
$141.20M(+91.8%)
$347.90M(+18.1%)
Jun 2023
-
$73.60M(+147.8%)
$294.50M(+6.9%)
Mar 2023
-
$29.70M(-71.3%)
$275.60M(+10.7%)
Dec 2022
$249.00M(+19.8%)
$103.40M(+17.8%)
$249.00M(+18.8%)
Sep 2022
-
$87.80M(+60.5%)
$209.60M(+26.0%)
Jun 2022
-
$54.70M(+1664.5%)
$166.30M(-7.3%)
Mar 2022
-
$3.10M(-95.2%)
$179.40M(-13.7%)
Dec 2021
$207.80M(-36.5%)
$64.00M(+43.8%)
$207.80M(-3.6%)
Sep 2021
-
$44.50M(-34.4%)
$215.60M(-12.1%)
Jun 2021
-
$67.80M(+115.2%)
$245.30M(-18.3%)
Mar 2021
-
$31.50M(-56.1%)
$300.10M(-8.4%)
Dec 2020
$327.50M(+44.5%)
$71.80M(-3.2%)
$327.50M(-3.9%)
Sep 2020
-
$74.20M(-39.5%)
$340.70M(-4.5%)
Jun 2020
-
$122.60M(+108.1%)
$356.60M(+30.4%)
Mar 2020
-
$58.90M(-30.7%)
$273.40M(+20.7%)
Dec 2019
$226.60M(+444.7%)
$85.00M(-5.7%)
$226.60M(+34.7%)
Sep 2019
-
$90.10M(+128.7%)
$168.18M(+27.0%)
Jun 2019
-
$39.40M(+225.6%)
$132.40M(+45.3%)
Mar 2019
-
$12.10M(-54.5%)
$91.15M(+119.1%)
Dec 2018
$41.60M(+141.0%)
$26.58M(-51.1%)
$41.60M(-26.8%)
Sep 2018
-
$54.32M(+3033.2%)
$56.86M(+1743.3%)
Jun 2018
-
-$1.85M(+95.1%)
-$3.46M(+94.1%)
Mar 2018
-
-$37.45M(-189.5%)
-$58.88M(+41.9%)
Dec 2017
-$101.36M(+31.2%)
$41.83M(+797.8%)
-$101.36M(+46.5%)
Sep 2017
-
-$6.00M(+89.5%)
-$189.45M(+14.6%)
Jun 2017
-
-$57.27M(+28.4%)
-$221.89M(-7.5%)
Mar 2017
-
-$79.93M(-72.8%)
-$206.45M(-40.1%)
Dec 2016
-$147.37M(-56.4%)
-$46.25M(-20.3%)
-$147.37M(-11.8%)
Sep 2016
-
-$38.44M(+8.1%)
-$131.87M(-2.0%)
Jun 2016
-
-$41.83M(-100.5%)
-$129.28M(-14.6%)
Mar 2016
-
-$20.86M(+32.2%)
-$112.77M(-19.7%)
Dec 2015
-$94.20M(-46.3%)
-$30.75M(+14.2%)
-$94.20M(-12.2%)
Sep 2015
-
-$35.84M(-41.6%)
-$83.92M(-29.2%)
Jun 2015
-
-$25.32M(-1006.7%)
-$64.94M(-20.3%)
Mar 2015
-
-$2.29M(+88.8%)
-$53.97M(+16.2%)
Dec 2014
-$64.41M(-29.7%)
-$20.47M(-21.4%)
-$64.41M(-16.1%)
Sep 2014
-
-$16.86M(-17.4%)
-$55.47M(-9.6%)
Jun 2014
-
-$14.36M(-12.9%)
-$50.62M(-2.4%)
Mar 2014
-
-$12.72M(-10.4%)
-$49.43M(+0.5%)
Dec 2013
-$49.68M(-3530.8%)
-$11.53M(+4.0%)
-$49.68M(-68.0%)
Sep 2013
-
-$12.01M(+8.8%)
-$29.57M(-37.4%)
Jun 2013
-
-$13.17M(-1.5%)
-$21.52M(-121.1%)
Mar 2013
-
-$12.97M(-251.2%)
-$9.73M(-772.3%)
Dec 2012
$1.45M(-95.7%)
$8.58M(+316.6%)
$1.45M(+121.7%)
Sep 2012
-
-$3.96M(-187.1%)
-$6.69M(-124.1%)
Jun 2012
-
-$1.38M(+23.0%)
$27.71M(-8.2%)
Mar 2012
-
-$1.79M(-500.9%)
$30.19M(-11.0%)
Dec 2011
$33.92M(+347.2%)
$447.00K(-98.5%)
$33.92M(+1.7%)
Sep 2011
-
$30.44M(+2677.4%)
$33.35M(+520.7%)
Jun 2011
-
$1.10M(-43.5%)
$5.37M(+432.8%)
Mar 2011
-
$1.94M(+1603.1%)
-$1.61M(+88.2%)
Dec 2010
-$13.72M
-$129.00K(-105.2%)
-$13.72M(+47.0%)
DateAnnualQuarterlyTTM
Sep 2010
-
$2.47M(+141.9%)
-$25.87M(+31.9%)
Jun 2010
-
-$5.89M(+42.1%)
-$37.97M(+19.2%)
Mar 2010
-
-$10.17M(+17.2%)
-$46.99M(+8.1%)
Dec 2009
-$51.11M(+40.0%)
-$12.28M(-27.5%)
-$51.11M(+24.3%)
Sep 2009
-
-$9.63M(+35.4%)
-$67.50M(+8.3%)
Jun 2009
-
-$14.90M(-4.2%)
-$73.57M(+6.6%)
Mar 2009
-
-$14.30M(+50.1%)
-$78.78M(+7.6%)
Dec 2008
-$85.25M(+59.8%)
-$28.66M(-82.5%)
-$85.25M(+54.0%)
Sep 2008
-
-$15.70M(+21.9%)
-$185.18M(+6.6%)
Jun 2008
-
-$20.12M(+3.1%)
-$198.30M(+3.6%)
Mar 2008
-
-$20.76M(+83.9%)
-$205.73M(+3.1%)
Dec 2007
-$212.24M(-87.3%)
-$128.59M(-346.1%)
-$212.24M(-112.4%)
Sep 2007
-
-$28.83M(-4.6%)
-$99.91M(+10.2%)
Jun 2007
-
-$27.55M(-1.0%)
-$111.28M(+1.5%)
Mar 2007
-
-$27.27M(-67.7%)
-$113.00M(+0.3%)
Dec 2006
-$113.32M(-352.0%)
-$16.26M(+59.5%)
-$113.32M(+6.8%)
Sep 2006
-
-$40.20M(-37.4%)
-$121.65M(-116.0%)
Jun 2006
-
-$29.26M(-6.1%)
-$56.33M(-69.1%)
Mar 2006
-
-$27.59M(-12.2%)
-$33.32M(-32.9%)
Dec 2005
-$25.07M(+52.1%)
-$24.59M(-197.9%)
-$25.07M(-15.7%)
Sep 2005
-
$25.12M(+501.8%)
-$21.66M(+56.5%)
Jun 2005
-
-$6.25M(+67.7%)
-$49.81M(+12.5%)
Mar 2005
-
-$19.35M(+8.7%)
-$56.95M(-8.8%)
Dec 2004
-$52.33M(+11.0%)
-$21.18M(-598.9%)
-$52.33M(-7.9%)
Sep 2004
-
-$3.03M(+77.4%)
-$48.52M(+17.9%)
Jun 2004
-
-$13.39M(+9.1%)
-$59.06M(-1.5%)
Mar 2004
-
-$14.73M(+15.2%)
-$58.16M(+1.1%)
Dec 2003
-$58.79M(+43.3%)
-$17.37M(-28.0%)
-$58.79M(+28.9%)
Sep 2003
-
-$13.57M(-8.7%)
-$82.69M(+9.7%)
Jun 2003
-
-$12.49M(+18.6%)
-$91.62M(+9.4%)
Mar 2003
-
-$15.35M(+62.8%)
-$101.15M(+2.4%)
Dec 2002
-$103.61M(-136.1%)
-$41.27M(-83.4%)
-$103.61M(-33.3%)
Sep 2002
-
-$22.50M(-2.2%)
-$77.75M(-43.8%)
Jun 2002
-
-$22.02M(-23.6%)
-$54.05M(-13.5%)
Mar 2002
-
-$17.82M(-15.7%)
-$47.62M(-8.5%)
Dec 2001
-$43.88M(-23.3%)
-$15.40M(-1391.2%)
-$43.88M(-10.3%)
Sep 2001
-
$1.19M(+107.7%)
-$39.79M(+21.5%)
Jun 2001
-
-$15.59M(-10.7%)
-$50.67M(-19.3%)
Mar 2001
-
-$14.08M(-24.5%)
-$42.45M(-19.2%)
Dec 2000
-$35.60M(-78.9%)
-$11.31M(-16.8%)
-$35.60M(-21.5%)
Sep 2000
-
-$9.69M(-31.2%)
-$29.29M(-19.0%)
Jun 2000
-
-$7.38M(-2.1%)
-$24.61M(-9.3%)
Mar 2000
-
-$7.23M(-44.5%)
-$22.52M(-13.8%)
Dec 1999
-$19.90M(-60.5%)
-$5.00M(0.0%)
-$19.79M(-7.0%)
Sep 1999
-
-$5.00M(+5.5%)
-$18.49M(-11.5%)
Jun 1999
-
-$5.29M(-17.6%)
-$16.59M(-12.9%)
Mar 1999
-
-$4.50M(-21.6%)
-$14.70M(-16.7%)
Dec 1998
-$12.40M(-2580.0%)
-$3.70M(-19.4%)
-$12.60M(-23.5%)
Sep 1998
-
-$3.10M(+8.8%)
-$10.20M(-36.0%)
Jun 1998
-
-$3.40M(-41.7%)
-$7.50M(-50.0%)
Mar 1998
-
-$2.40M(-84.6%)
-$5.00M(-933.3%)
Dec 1997
$500.00K(-82.8%)
-$1.30M(-225.0%)
$600.00K(-88.5%)
Sep 1997
-
-$400.00K(+55.6%)
$5.20M(+26.8%)
Jun 1997
-
-$900.00K(-128.1%)
$4.10M(-34.9%)
Mar 1997
-
$3.20M(-3.0%)
$6.30M(+117.2%)
Dec 1996
$2.90M
$3.30M(+320.0%)
$2.90M(+825.0%)
Sep 1996
-
-$1.50M(-215.4%)
-$400.00K(-136.4%)
Jun 1996
-
$1.30M(+750.0%)
$1.10M(+650.0%)
Mar 1996
-
-$200.00K
-$200.00K

FAQ

  • What is Neurocrine Biosciences, Inc. annual operating income?
  • What is the all-time high annual operating profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual operating profit year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly operating profit year-on-year change?
  • What is Neurocrine Biosciences, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. TTM operating profit year-on-year change?

What is Neurocrine Biosciences, Inc. annual operating income?

The current annual operating profit of NBIX is $583.00M

What is the all-time high annual operating profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual operating income is $583.00M

What is Neurocrine Biosciences, Inc. annual operating profit year-on-year change?

Over the past year, NBIX annual operating income has changed by +$188.20M (+47.67%)

What is Neurocrine Biosciences, Inc. quarterly operating income?

The current quarterly operating profit of NBIX is $145.60M

What is the all-time high quarterly operating profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly operating income is $184.80M

What is Neurocrine Biosciences, Inc. quarterly operating profit year-on-year change?

Over the past year, NBIX quarterly operating income has changed by -$2.30M (-1.56%)

What is Neurocrine Biosciences, Inc. TTM operating income?

The current TTM operating profit of NBIX is $499.10M

What is the all-time high TTM operating profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high TTM operating income is $588.30M

What is Neurocrine Biosciences, Inc. TTM operating profit year-on-year change?

Over the past year, NBIX TTM operating income has changed by -$45.60M (-8.37%)
On this page